Tasly Pharmaceutical Group Co., Ltd. engages in the development, manufacture and distribution of pharmaceutical products. Its products include herbal medicines, chemical medicines, pharmaceutical substances, herbal extract and tea products, cosmetics and daily hygiene products, and medical equipment. The company was founded on May 10, 1994 and is headquartered in Tianjin, China.

Jiangsu Carephar Pharmaceutical Co., Ltd. engages in the manufacture, research and development of pharmaceutical products. It sells and develops Chinese medicine, antibiotic drugs, biochemical drugs, chemical agents and other pharmaceutical products. The company was founded on June 8, 2006 and is headquartered in Nanjing, China.

Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd., established on 2017-05-25, Business scope includes medical research and experimental development;technology development,technology transfer,technical consulting,Technical Services,Technical testing;Technology Import and Export,Import and export;Conference Services;Undertake exhibition and display activities.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Beijing Huaguan Pharmaceutical Technology Co., Ltd., established on 2016-03-01, Business scope includes technology development,technical consulting,Technical Services,technology transfer,Technology Promotion;Sales of chemical products(Free of Hazardous Chemicals);Technical testing;Technology Import and Export,Import and export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Botanic Century (Beijing) Co. Ltd. is a private company headquartered in Beijing, China. The firm develops and manufactures pharmaceutical drugs.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd is a joint venture company headquartered in Guangzhou, China. The firm manufactures, markets and distributes OTC pharmaceutical products. It was founded in 2005.

Guiyang Yunyan Xichuang Pharmaceutical Technology Development Co., Ltd., established on 2004-06-16, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(traditional Chinese medicine,Western medicine,Health products,Chemical Products(Except for special items)and technology development of biological products,technology transfer.(The following blank)(2009year3moon30Daily photo change))

The chemical treatment market is being actively used by the firm. Tumor, cardiovascular and cerebrovascular, women and children, and other therapeutic regions will be included for biological pharmaceuticals, chemical drug imitations, new research and development, and other collaboration and layout methods. In the future, Yibai plans to grow its pharmaceutical manufacturer, consolidate its major pharmaceutical industry, and build two new sources of growth for biological and chemical pharmaceuticals based on traditional Chinese medicine.

Beijing Asia-East Bio-Pharmaceutical Co., Ltd engages in research & development and production of pharmaceutical products. It produces medicines that are used in the treatment of liver tumor, gynaecological, pediatric, diabetes, cardiovascular, rheumatism, urogenital, cold and asthma disease. The company was founded on May 25, 1991 and is headquartered in Beijing, China.

Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. It offers medicines in the form of tablets, capsules, syrups, soft capsules, granules, pills, powder, sprays, creams, and injections. Its products are used for the treatment of cardiovascular and cerebrovascular diseases, cough, common cold, and fever. The company was founded on March 25, 1999 and is headquartered in Anshun, China.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Shanghai Star Leaf Pharmaceutical Technology Co., Ltd., established on 2017-12-18, The scope of business includes engaging in medical technology,Technical consulting in the field of biotechnology,technology development,technology transfer,Technical Services,R&D and sales of pharmaceutical intermediates,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

China Pharmaceutical Holdings Co., Ltd., established on 2014-05-04, Business scope includes services:Industrial Investment,medical products,medical instruments,Technology Development of Biologics,Achievement transfer;Wholesale and retail:Chemical Products(Removal of hazardous chemicals and precursor chemicals),Pharmaceutical engineering equipment;Import and export(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license).

Jiangyin Tianjiang Pharmaceutical Co., Ltd. produces traditional Chinese medicines. Its product TCM formula particles series made relying on modern science and technology, by simulating traditional decoction method of traditional Chinese medicine decoction as well as by extracting, filtering, concentrating and drying TCM decocting pieces. The company was founded in 1992 and is headquartered in Jiangyin, China.

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production and sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. It provides blood tumors, gynecology, pediatrics, skin and orthopedic drugs; phosphate buffered saline and polyvinyl butyral products; vitamin B5; and original B5. The company was founded on November 10, 2000 and is headquartered in Hangzhou, China.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Jenkem Technology Co., Ltd. engages in the research, development, production and sales of medical polyethylene glycol (PEG) and its active derivatives. Its products include Y-shape maleimide, glucose PEG succinimidyl carboxymethyl ester, biotin PEG succinimidyl glutaramide and hydroxyl PEG 12 propionic acid. The company was founded by Shi Shan Kai, Zhu Hua Zhao and De Quan Zhu on October 9, 2001 and is headquartered in Beijing, China.

Guangzhou Meichen Pharmaceutical Co., Ltd., established on 2000-12-15, Business scope includes manufacturing,processing:tablet,Capsules,Granules,Pills,soft capsule.Traditional Chinese medicine pretreatment and extraction workshop(Oral preparations).(The drug production license is valid until2010year12moon31day).Wholesale and retail trade(Excludes state-exclusively controlled products).*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of medicine. It mainly focuses on Chinese medicines formulations, aid digestion medicines, vitamin medicines, dermatology drugs, anti-parasitic drugs, ophthalmic solution, chemicals and respiratory system drugs. The company was founded on December 31, 2001 and is headquartered in Dongguan, China.